atumelnant (CRN04894) clinical trials

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

This study looks at the long-term safety and effectiveness of a new medicine, atumelnant, for people with Congenital Adrenal Hyperplasia (CAH). It's for those who have already tried atumelnant in a previous study and could benefit from continuing it.